Acetaminophen
- Product NDC
- 68071-3454
- 11-digit product format
- 680713454
- Labeler code
- 68071
- Product ID
- 68071-3454_404529fa-4eba-d862-e063-6394a90a08b9
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-03-11
- Substance
- ACETAMINOPHEN
- Active strength
- 325 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 68071-3454-4 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 68071-3454-3 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 68071-3454-5 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 68071-3454-4 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 68071-3454-3 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 68071-3454-5 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 68071-3454-4 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 68071-3454-3 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 68071-3454-5 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 68071-3454-4 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 68071-3454-3 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 68071-3454-5 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 68071-3454-4 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 68071-3454-3 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 68071-3454-5 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 68071-3454-5 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 68071-3454-3 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 68071-3454-4 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 68071-3454-5 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 68071-3454-3 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 68071-3454-4 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 68071-3454-5 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 68071-3454-3 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 68071-3454-4 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acetaminophen
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 325 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 313782 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 004c39cd-b4f4-1cae-e063-6394a90a0697 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 68071-3454-3 | 2025-10-03 | Drug Facts |
| 68071-3454-4 | 2025-10-03 | Drug Facts |
| 68071-3454-5 | 2025-10-03 | Drug Facts |
| 68071-3454-3 | 2025-01-30 | Drug Facts |
| 68071-3454-4 | 2025-01-30 | Drug Facts |
| 68071-3454-5 | 2025-01-30 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3454-3 | Acetaminophen | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 5 | |
| 68071-3454-4 | Acetaminophen | 40 in 1 BOTTLE, PLASTIC | TABLET | 40 | 5 | |
| 68071-3454-5 | Acetaminophen | 50 in 1 BOTTLE, PLASTIC | TABLET | 50 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-3454 | ACETAMINOPHEN TABLET [NUCARE PHARMACEUTICALS,INC.] | 4 | Current NDC, 3 package rows | 20230929_004c39cd-b4f4-1cae-e063-6394a90a0697.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | P & L Development, LLC | 55e996cd-ef22-4e09-a05c-8aa994e4540b | 2026-06-12 | Warnings | M013 |
| CHILDRENS TYLENOL | ACETAMINOPHEN | Kenvue Brands LLC | 3162733b-9382-39f1-e063-6294a90ac420 | 2026-06-12 | Warnings | M013 |
| Acetaminophen Extra Strength | ACETAMINOPHEN | Dr. Reddy's Laboratories Inc. | 9769e0c0-2f4c-3b7a-1a65-c98fbce11681 | 2026-06-12 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | NuCare Pharmaceuticals, Inc. | 54010ddf-25d1-2016-e063-6294a90a877d | 2026-06-11 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | Preferred Pharmaceuticals Inc. | 983debdf-4a61-4dde-ba34-567fdd17720e | 2026-06-11 | Warnings | M013 |
| Acetaminophen Liquid / Acetaminophen Diphenhydramine HCl Liquid | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | WALGREENS | 40b4fe91-b1dd-147c-e063-6294a90a807d | 2026-06-09 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | PUBLIX SUPERMARKETS, INC | 3f17fa06-4932-b8ec-e063-6294a90a0381 | 2026-06-09 | Warnings | M013 |
| Sleep Aid Plus Pain Relief | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Walgreen Company | e3929179-dad2-4f7e-a971-dbf80f2b5e1b | 2026-06-08 | Warnings | M013 |
| LOW DOSE ASPIRIN | ASPIRIN | Pinnacle RX LLC | 53c11fb4-ba31-b5e5-e063-6394a90a9c1a | 2026-06-08 | Warnings | M013 |
| Pain Reliever PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Walgreen Company | 9655c38a-126b-459e-b31d-0aa33d9eb522 | 2026-06-08 | Warnings | M013 |
| Acetaminophen Regular Strength | ACETAMINOPHEN | Aurohealth LLC | dce938f5-eeba-4a76-9261-2b1324c39a31 | 2026-06-08 | Warnings | M013 |
| Childrens Mapap | ACETAMINOPHEN | Bryant Ranch Prepack | 69c90cc8-846a-42cf-933a-108671689e8f | 2026-06-05 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | Rugby Laboratories | 63fcd93a-b1db-44ba-8f2b-055a7deb205d | 2026-06-04 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | ASCLEMED USA INC. | 707a9ea7-8f4e-4274-97bd-b8071a0ee06b | 2026-06-04 | Warnings | M013 |
| Aspirin Adult low dose | ACETYLSALICYCLIC ACID | Medline Industries, LP | 6dd6501f-841c-4994-e053-2a91aa0ae231 | 2026-06-04 | Warnings | M013 |
| Medline | ACETAMINOPHEN | Medline Industries, LP | fc5e6f2a-e813-0666-e053-6394a90a66a7 | 2026-06-04 | Warnings | M013 |
| Medline | ACETAMINOPHEN | Medline Industries, LP | fc5d92c2-4bbe-8ad1-e053-6294a90a65b6 | 2026-06-04 | Warnings | M013 |
| acetaminophen | ACETAMINOPHEN | Unit Dose Solutions, Inc. | 537219ac-552a-a30e-e063-6394a90aa9d1 | 2026-06-04 | Warnings | M013 |
| Pain Relief childrens | ACETAMINOPHEN | CVS PHARMACY | ff878f56-125a-4de7-b063-029f7030733d | 2026-06-04 | Warnings | M013 |
| Back and Body Extra Strength | ASPIRIN, CAFFEINE | CVS Pharmacy | 749e2be2-594a-4052-8fa5-45c9ade2d23c | 2026-06-03 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 313782 | acetaminophen 325 MG Oral Tablet | PSN | 004c39cd-b4f4-1cae-e063-6394a90a0697 | 5 |
| 313782 | acetaminophen 325 MG Oral Tablet | SCD | 004c39cd-b4f4-1cae-e063-6394a90a0697 | 5 |
| 313782 | APAP 325 MG Oral Tablet | SY | 004c39cd-b4f4-1cae-e063-6394a90a0697 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 68071-3454-3 | 68071345403 | 30 TABLET in 1 BOTTLE, PLASTIC (68071-3454-3) | 30 tablet | 2023-07-12 | No | No | Current |
| 68071-3454-4 | 68071345404 | 40 TABLET in 1 BOTTLE, PLASTIC (68071-3454-4) | 40 tablet | 2023-07-12 | No | No | Current |
| 68071-3454-5 | 68071345405 | 50 TABLET in 1 BOTTLE, PLASTIC (68071-3454-5) | 50 tablet | 2023-07-12 | No | No | Current |